Arrow Mark Colorado Holdings LLC Veracyte, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

  • $6.65 Billion
  • Q4 2024

A detailed history of Arrow Mark Colorado Holdings LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 3,080,027 shares of VCYT stock, worth $121 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares
3,080,027
Previous 2,982,203 3.28%
Holding current value
$121 Million
Previous $101 Million 20.19%
% of portfolio
1.83%
Previous 1.44%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$31.92 - $44.4 $3.12 Million - $4.34 Million
97,824 Added 3.28%
3,080,027 $122 Million
Q3 2024

Nov 14, 2024
SELL
$21.0 - $35.25 $327,180 - $549,195
-15,580 Reduced 0.52%
2,982,203 $101 Million
Q2 2024

Aug 14, 2024
BUY
$18.86 - $23.55 $6.69 Million - $8.35 Million
354,538 Added 13.41%
2,997,783 $65 Million
Q1 2024

May 15, 2024
BUY
$21.0 - $29.1 $2.65 Million - $3.67 Million
126,105 Added 5.01%
2,643,245 $58.6 Million
Q4 2023

Feb 14, 2024
BUY
$19.72 - $28.68 $2.49 Million - $3.62 Million
126,161 Added 5.28%
2,517,140 $69.2 Million
Q2 2023

Aug 14, 2023
BUY
$20.96 - $26.99 $3.74 Million - $4.82 Million
178,414 Added 8.06%
2,390,979 $60.9 Million
Q1 2023

May 15, 2023
SELL
$20.58 - $27.89 $11.9 Million - $16.1 Million
-577,105 Reduced 20.69%
2,212,565 $49.3 Million
Q4 2022

Feb 14, 2023
SELL
$15.31 - $29.94 $914,772 - $1.79 Million
-59,750 Reduced 2.1%
2,789,670 $66.2 Million
Q3 2022

Nov 14, 2022
SELL
$16.58 - $27.9 $14.1 Million - $23.8 Million
-852,556 Reduced 23.03%
2,849,420 $47.3 Million
Q2 2022

Aug 15, 2022
BUY
$15.45 - $29.52 $9.46 Million - $18.1 Million
612,533 Added 19.83%
3,701,976 $73.7 Million
Q1 2022

May 16, 2022
BUY
$21.94 - $42.51 $12.3 Million - $23.9 Million
562,021 Added 22.24%
3,089,443 $85.2 Million
Q4 2021

Feb 14, 2022
BUY
$36.09 - $53.79 $655,827 - $977,471
18,172 Added 0.72%
2,527,422 $104 Million
Q3 2021

Nov 15, 2021
SELL
$35.62 - $52.97 $831,299 - $1.24 Million
-23,338 Reduced 0.92%
2,509,250 $117 Million
Q2 2021

Aug 16, 2021
BUY
$32.94 - $56.62 $33.2 Million - $57.1 Million
1,008,289 Added 66.15%
2,532,588 $101 Million
Q1 2021

May 17, 2021
BUY
$44.47 - $81.38 $32.7 Million - $59.8 Million
735,121 Added 93.15%
1,524,299 $81.9 Million
Q4 2020

Feb 16, 2021
SELL
$32.49 - $61.88 $2.05 Million - $3.9 Million
-63,022 Reduced 7.4%
789,178 $38.6 Million
Q3 2020

Nov 16, 2020
SELL
$26.73 - $35.67 $7.29 Million - $9.72 Million
-272,583 Reduced 24.23%
852,200 $27.7 Million
Q2 2020

Aug 14, 2020
SELL
$19.49 - $28.11 $428 - $618
-22 Reduced -0.0%
1,124,783 $29.1 Million
Q1 2020

May 15, 2020
BUY
$16.13 - $30.17 $18.1 Million - $33.9 Million
1,124,805 New
1,124,805 $27.3 Million

Others Institutions Holding VCYT

# of Institutions
337
Shares Held
80.2M
Call Options Held
212K
Put Options Held
18.5K
View Full List

About VERACYTE, INC.

VCYT Quotes by TradingView
  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.8B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email